You have 3 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sodium phenylbutyrate

Showing 1 - 25 of 3,086
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Medium-chain Acyl-CoA Dehydrogenase Deficiency Trial in Pittsburgh (Sodium phenylbutyrate)

Recruiting
  • Medium-chain Acyl-CoA Dehydrogenase Deficiency
  • Sodium phenylbutyrate
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Oct 4, 2023

Hyperammonemia Trial in Belfast (Fezagepras, Sodium phenylbutyrate)

Terminated
  • Hyperammonemia
  • Belfast, Northern Ireland, United Kingdom
    Celerion
Jul 28, 2022

Obese Non Diabetic Trial in Derby (sodium phenylbutyrate)

Recruiting
  • Obese Non Diabetic
  • sodium phenylbutyrate
  • Derby, Derbyshire, United Kingdom
    University of Nottingham
Aug 25, 2021

Wolfram Syndrome Trial (AMX0035)

Not yet recruiting
  • Wolfram Syndrome
  • (no location specified)
Dec 22, 2022

Pyruvate Dehydrogenase Complex Deficiency Trial in Napoli (sodium phenylbutyrate)

Completed
  • Pyruvate Dehydrogenase Complex Deficiency
  • sodium phenylbutyrate
  • Napoli, Italy
    Federico II University
Oct 5, 2021

Alzheimer Trial in United States (AMX0035, Placebo)

Completed
  • Alzheimer Disease
  • Jacksonville, Florida
  • +10 more
Nov 10, 2021

Amyotrophic Lateral Sclerosis Trial in Puerto Rico, United States (AMX0035)

Approved for marketing
  • Amyotrophic Lateral Sclerosis
  • Los Angeles, California
  • +20 more
Oct 14, 2022

STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder Trial in Aurora, New York (Glycerol Phenylbutyrate 1100

Active, not recruiting
  • STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder
  • Glycerol Phenylbutyrate 1100 MG/ML [Ravicti]
  • Aurora, Colorado
  • +1 more
Jan 24, 2023

Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Neuromuscular Diseases Trial in United States (AMX0035, Placebo)

Completed
Has Results
  • Amyotrophic Lateral Sclerosis
  • +7 more
  • Phoenix, Arizona
  • +24 more
Jul 20, 2021

Type 2 Diabetes Trial (4.8 g/m^2/day NaPB, 4.8 g/m^2/day )

Not yet recruiting
  • Type 2 Diabetes
  • 4.8 g/m^2/day NaPB
  • 4.8 g/m^2/day placebo
  • (no location specified)
Apr 26, 2023

Progressive Supranuclear Palsy, PSP, Neurodegenerative Diseases Trial (AMX0035, Placebo)

Not yet recruiting
  • Progressive Supranuclear Palsy
  • +3 more
  • (no location specified)
Nov 3, 2023

Cystic Fibrosis Trial in Denver, Baltimore, Philadelphia (Ravicti low dose, Ravicti high dose, Placebo)

Terminated
  • Cystic Fibrosis
  • Ravicti low dose
  • +2 more
  • Denver, Colorado
  • +2 more
Mar 4, 2022

Amyotrophic Lateral Sclerosis Trial in Worldwide (AMX0035)

Enrolling by invitation
  • Amyotrophic Lateral Sclerosis
  • Leuven, Belgium
  • +42 more
Jan 20, 2023

Monocarboxylate Transporter 8 Deficiency Trial in Rehovot (Glycerol Phenylbutyrate 1100 MG/ML)

Recruiting
  • Monocarboxylate Transporter 8 Deficiency
  • Glycerol Phenylbutyrate 1100 MG/ML
  • Rehovot, Israel
    Pediatric Endocrinology Unit, Kapan Medical Center
Aug 22, 2021

Hereditary Diseases, Cholestasis, Intrahepatic Trial (4-Phenylbutyrate)

Not yet recruiting
  • Hereditary Diseases
  • Cholestasis, Intrahepatic
  • (no location specified)
Aug 4, 2022

Amyotrophic Lateral Sclerosis, ALS Trial in Boston, Worcester (AMX0035)

Completed
  • Amyotrophic Lateral Sclerosis
  • ALS
  • Boston, Massachusetts
  • +1 more
Jan 5, 2022

Lymphoma, Small Intestine Cancer, Solid Tumor Trial in Baltimore (Azacitidine Injection, sodium phenylbutyrate)

Completed
  • Lymphoma
  • +2 more
  • Azacitidine Injection
  • sodium phenylbutyrate
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 9, 2019

Amyotrophic Lateral Sclerosis Trial in Worldwide (Placebo, AMX0035)

Active, not recruiting
  • Amyotrophic Lateral Sclerosis
  • Phoenix, Arizona
  • +68 more
Jan 4, 2023

Amyotrophic Lateral Sclerosis, ALS Trial in Tel Aviv (PrimeC, Placebo)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • ALS
  • Loma Linda, California
  • +2 more
Nov 23, 2022

Amyotrophic Lateral Sclerosis Trial in United States (AMX0035)

Enrolling by invitation
  • Amyotrophic Lateral Sclerosis
  • San Francisco, California
  • +4 more
Jul 20, 2021

Malignant Mesothelioma Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

Terminated
Has Results
  • Malignant Mesothelioma
  • Antineoplaston therapy (Atengenal + Astugenal)
  • Houston, Texas
    Burzynski Clinic
Mar 31, 2021

Urea Cycle Disorder Trial in Blue Bell

Terminated
Has Results
  • Urea Cycle Disorder
    • Blue Bell, Pennsylvania
      United BioSource Corporation
    Feb 1, 2021

    Corticobasal Syndrome (CBS) Trial (RAVICTI 1.1 g/ml, Placebo)

    Not yet recruiting
    • Corticobasal Syndrome (CBS)
    • RAVICTI 1.1 g/ml
    • Placebo
    • (no location specified)
    Aug 1, 2023

    Parkinson's Disease Trial in Aurora (Glycerol Phenylbutyrate)

    Completed
    • Parkinson's Disease
    • Glycerol Phenylbutyrate
    • Aurora, Colorado
      University of Colorado Denver Anschutz Medical Center
    Apr 15, 2022

    Plasma Sodium and Sodium Administration in the ICU

    Recruiting
    • Hypernatremia
    • +2 more
      • Linköping, Sweden
        University Hospital Linköping
      Sep 15, 2023